Provider Information: Harm Reduction and Overdose Prevention:
Harm Reduction and Overdose Prevention:
Encourage patients (and their family and friends) to carry naloxone:
Any licensed prescriber can write a prescription for naloxone, which patients can fill in a pharmacy. Any licensed prescriber can also write a prescription for naloxone for friends and family of a patient who is using opioids. For more information, click here. **Because of the increase in fentanyl and analogs, you may want to considerprescribing 3 units of naloxone instead of the standard two units*
To watch a video on how to talk to patients about naloxone in primary care and pain management settings, go here.
Per Illinois law, a pharmacist who has completed training can initiate naloxone dispensing without a physician prescription. The same Illinois law requires that all Medicaid plans must provide coverage for naloxone. To date, Walgreens has trained all of its pharmacists in Illinois to be able to do this. Many other individual and chain pharmacies have trained some pharmacists.
Overdose response education and naloxone distribution is also available through the Chicago Recovery Alliance (CRA). A schedule for the CRA mobile van can be found here.
Educate patients (and their family and friends) on harm reduction techniques to avoid overdose and death:
Avoid using drugs alone
Know your limits- do a “test shot” to see how strong the drug is (i.e., inject or snort a smaller amount than usual to make sure that the response is as expected)
Avoid mixing drugs when possible, especially multiple “downers” that can cause respiratory depression
Carry an overdose rescue kit (naloxone) and be sure others know you have it
Encourage patients and families to check out the CDPH website: "Overcome Opioids" (www.overcomeopioids.org) which includes general information and local resources.
AMA Video: How to Use Naloxone
Please enter a valid video URL.
The URL can point to any video file or a Youtube video.
Opioid Related Epidemiology Briefs
See links below for recent opioid-related epidemiology briefs: